ACS Medicinal Chemistry Letters · 2021 · 11 citations · 22 references
Life SciencesImmunologyMedicinal ChemistryAutoimmunityDrug DiscoveryImmunoregulationAllosteric ModulationAllosteric RegulationChemical Probe DiscoveryCytokine BiologyInflammatory SignalingLigand BindingAllosteric Ligand BindingAllosteric Ligand DiscoveryAllosteric ProbesCovalent Chemical ProbesOrthosteric Binding SitesOrthosteric InteractionsT Helper 17 DifferentiationTh17 Cell Differentiation
The nuclear receptor RORγt is a key positive regulator in the differentiation and proliferation of T helper 17 (Th17) cells and the production of proinflammatory cytokines like IL-17a. Dysregulation of this pathway can result in the development of various autoimmune diseases, and inhibition of RORγt with small molecules thus holds great potential as a therapeutic strategy. RORγt has a unique allosteric ligand binding site in the ligand binding domain, which is distinct from the canonical, orthosteric binding site. Allosteric modulation of RORγt shows high potential, but the targeted discovery of novel allosteric ligands is highly challenging via currently available methods. Here, we introduce covalent, orthosteric chemical probes for RORγt that occlude the binding of canonical, orthosteric ligands but still allow allosteric ligand binding. Ultimately, these probes could be used to underpin screening approaches for the unambiguous and rapid identification of novel allosteric RORγt ligands.
22
Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
Jun R. Huh, Monica Leung, Pengxiang Huang et al. · Nature · 2011 · 536 citations
Naresh Kumar, Laura A. Solt, Juliana J. Conkright et al. · Molecular Pharmacology · 2009 · 237 citations · Full text